Open AccessJournal Article
Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors.
Ken Samoto,Kiyonobu Ikezaki,Mayumi Ono,Tadahisa Shono,Kimitoshi Kohno,Michihiko Kuwano,Masashi Fukui +6 more
Reads0
Chats0
TLDR
It is suggested that VEGF may be a positive factor in tumor angiogenesis in both human gliomas and meningiomas.Abstract:
To examine which growth factors correlate with neovascularization in human brain tumors, the mRNA levels of transforming growth factor α, transforming growth factor, β, basic fibroblast growth factor, and vascular endothelial growth factor (VEGF) genes were determined by a Northern blot analysis in surgically obtained human gliomas and meninglomas The vascular development was determined by counting the number of microvessels which were immunostained with von Willebrand factor We normalized the growth factor mRNA levels versus the glyceraldehyde phosphate dehydrogenase mRNA level In the 17 gliomas and 16 meningiomas examined, the mRNA of transforming growth factors α and β, basic fibroblast growth factor, and VEGF were expressed at various levels Among those 4 growth factors, the mRNA levels of VEGF, but not those of transforming growth factors α and β and basic fibroblast growth factor, correlated significantly with vascularity in both gliomas (correlation coefficient r = 0499; P < 005) and meningiomas (correlation coefficient r = 0779; P < 0001) These findings thus suggest that VEGF may be a positive factor in tumor angiogenesis in both human gliomas and meningiomasread more
Citations
More filters
Journal ArticleDOI
Angiogenesis in brain tumours
Rakesh K. Jain,Emmanuelle di Tomaso,Dan G. Duda,Jay S. Loeffler,A. Gregory Sorensen,Tracy T. Batchelor +5 more
TL;DR: Emerging preclinical and clinical data indicate that anti-VEGF therapies are potentially effective in glioblastoma and can transiently normalize tumour vessels, creating a window of opportunity for optimally combining chemotherapeutics and radiation.
PatentDOI
Tyrosine kinase inhibitors
TL;DR: In this article, the imidazo[1,2-a]pyrimidine derivatives are used for treating cellular proliferative diseases, for treating disorders associated with MET activity, and for inhibiting the receptor tyrosine kinase MET.
Journal ArticleDOI
Vascular endothelial growth factor
Karl H. Plate,Peter C. Warnke +1 more
TL;DR: The approaches to inhibittumor angiogenesis and edema formation in glioblastoma patients will concentrate on the disruption of VEGF/VEGF receptorsignal transduction pathway in vivo.
Journal ArticleDOI
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation
P. E. Vermeulen,Giampietro Gasparini,Stephen B. Fox,Masakazu Toi,L. Martin,Peter McCulloch,Francesco Pezzella,Giuseppe Viale,Noel Weidner,Adrian L. Harris,Luc Dirix +10 more
TL;DR: ‘Angiogenesis Group, Department of Oncology, Antwerp University Hospital, Wilrijkstraat 10, B-2650 Edegem, Belgium'; ‘ICRF Molecular Oncologists, University of Oxford, Oxford, U.K.
Journal ArticleDOI
Transforming Growth Factor-beta: Vasculogenesis, Angiogenesis, and Vessel Wall Integrity
TL;DR: Although the focus of this review will be on the endothelium, other vascular wall cells are also likely to be important in the pathogenesis of the vascular lesions revealed by genetic studies.